MEIP — MEI PHARMA INC

Ownership history in MACQUARIE GROUP LTD  ·  31 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in MEI PHARMA INC (MEIP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 29,999 — 0% 0.00% $73K —
2025 Q2 UNCHANGED 29,999 — 0% 0.00% $74K —
2025 Q1 UNCHANGED 29,999 — 0% 0.00% $66K —
2024 Q4 UNCHANGED 29,999 — 0% 0.00% $74K —
2024 Q3 UNCHANGED 29,999 — 0% 0.00% $86K —
2024 Q2 UNCHANGED 29,999 — 0% 0.00% $87K —
2024 Q1 UNCHANGED 29,999 — 0% 0.00% $120K —
2023 Q4 UNCHANGED 29,999 — 0% 0.00% $174K —
2023 Q3 REDUCED 29,999 -570,001 -95.0% 0.00% $210K —
2023 Q1 UNCHANGED 600,000 — 0% 0.00% $137K —
21 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MEIP price (monthly, adj. close)

Other funds also holding MEIP

As of 2025 Q4 — sorted by position size

MOZAYYX MANAGEMENT LLC 0.58% Quarry LP 3Y 0.04% Alpine Global Management, LLC 3Y 7Y 0.01% ADAR1 Capital Management, LLC 0.01% Polar Asset Management Partners Inc. 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% Virtu Financial LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0%
← Back to MACQUARIE GROUP LTD Holdings